Molecular characterization of multidrug-resistant (MDR) Escherichia coli in the Greater Accra Region, Ghana: a ‘One Health’ approach.

Author:

Olu-Taiwo Michael A.1ORCID,Egyir Beverly2,Owusu-Nyantakyi Christian2,Forson Akua Obeng1,Opintan 3

Affiliation:

1. University of Ghana

2. University of Ghana Noguchi Memorial Institute for Medical Research

3. UGMS: University of Ghana Medical School

Abstract

Abstract

Background: ‘One health’, a concept that highlights the need to bring on board multiple players and actors together to addressing major health problems, have been proposed to be effective in data gathering to mitigate the menace of antimicrobial drug resistance (AMR). Data on MDR and extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) across humans, animals and the environment are limited in low-and-middle-income-countries (LMICs) including Ghana. Objective: This study used one health approach to determine the prevalence, antibiogram and AMR genes of ESBL-EC from diverse sources. Methodology: A cross-sectional study conducted in the Accra and Tema metropolis, Ghana. We randomly collected 1500 non-duplicated specimens from healthy human, cattle, pigs, lettuce, spring onions, pork, beef and soil samples. Escherichia coli(E. coli) was isolated and confirmed by MALDI-TOF MS. E. coli isolates were screened for their susceptibility against 13 antibiotic agents and ESBL-production. ESBL-ECisolates were whole-genome sequenced (WGS) and in silico analysis was used to determine AMR genes, sequence types (STs) and plasmid replicon types. Result: Overall, E. coli was recovered from 140 of 1500 (9.3%) specimens processed. About one-third of these E. coli isolates 50 (35.7%) were resistant to three or more antibiotics, and 30 (21.5%) were ESBL-EC. The proportion of ESBL-EC identified in healthy humans, cattle, pig, beef and soil were 14 (20.0%), 9 (22.5%), 3 (15.0%), 1 (50.0%) and 3 (37.5%), respectively. No E. coli was isolated from lettuce, spring onions and pork. Overall, the ESBL-EC exhibited high levels of resistance to ampicillin (100%), cefuroxime (100%), ciprofloxacin (53.6%), and to tetracycline (58.2%). However, all ESBL-EC isolates were sensitive to meropenem. The prevalent AMR genes detected were blaTEM-1B (32.0%; n=8), tetA (48.0%; n=12) and sul2 (32.0%; n=8). The dominant STs were ST10 (12%; n=3), ST 9312 (12%; n=3), ST 206 (12%; n=3) and ST 4151 (12%; n=3). IncFIB(Apoo1918) (40.0%; n=10) and IncFII(pCoo) (36.0%; n=9) plasmid replicons were commonly detected. Conclusion: Within the metropolis surveyed, we identified MDR ESBL-ECharbouring various AMR genes and plasmid replicons with diverse E. coliSTs in healthy humans, animals and the environment. This study finding of blaCTX-M-15 in agricultural soil isolate is worrisome, emphasizing the need for a one-health approach in combating AMR.

Publisher

Springer Science and Business Media LLC

Reference94 articles.

1. Aslam B, Khurshid M, Muzammil S, Rasool M, Arshad MI, Yasmeen N, Shah T, Chaudhry TH, Shahid A, Rasool MH, Xueshan X, Baloch Z. Antibiotic Resistance: One Health One World Outlook. Front. Cell. Infect. Microbiol. 2021;11:771510.

2. McEwen SA, Collignon PJ. Antimicrobial Resistance: a One Health Perspective. Microbiol Spectr. 2018;6(2). 10.1128/microbiolspec.ARBA-0009-2017.

3. The spread of antibiotic resistance to humans and potential protection strategies;Ding D;Ecotoxicol Environ Saf,2023

4. Measuring the global response to antimicrobial resistance, 2020–21: a systematic governance analysis of 114 countries;Patel J;Lancet Infect Dis,2023

5. What Is in the Salad? Escherichia coli and antibiotic resistance in lettuce irrigated with various water sources in Ghana;Quarcoo G;Int J Environ Res Public Health,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3